Evidence map›Paper›PMID 42918789›Full record

ArticleNature communications2026

XIST drives X-chromosome inactivation and safeguards female extraembryonic cells in humans.

Amitesh Panda, Léo Carrillo, Bradley Philip Balaton, Jeanne Brouillet, Solomon Nshemereirwe, Jarne Bonroy, Charbel Alfeghaly, Romina Facchinello, Sherif Khodeer, Nicolas Peredo and 17 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Amitesh Panda *Department of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-2702-3494
Léo Carrillo *Epigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Bradley Philip BalatonDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5130-7868
Jeanne BrouilletEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Solomon NshemereirweDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Jarne BonroyDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Charbel AlfeghalyEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.ORCID http://orcid.org/0000-0002-3189-900X
Romina FacchinelloEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Sherif KhodeerDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-6851-8568
Nicolas PeredoVIB BioImaging Core Leuven, VIB Technologies, Center for Neuroscience Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4670-3700
Ruben BoersDepartment of Developmental Biology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-3377-2897
Gael CastelEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.ORCID http://orcid.org/0000-0002-7563-1179
Charlie LondonEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Emmanuel CazottesEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.ORCID http://orcid.org/0000-0002-9583-2816
Madeleine MoscatelliEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France.
Raissa Songwa TchindaDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Thi Xuan Ai PhamDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-3866-2002
San Kit ToDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3057-2902
Ryan Nicolaas AllsopDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium.
Yang WangEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0003-2802-5392
Desislava StanevaLoke Center for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-1330-2158
Peter J Rugg-GunnEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-9601-5949
Kathy K NiakanEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0003-1646-4734
Joost GribnauDepartment of Developmental Biology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-5645-4691
Jean-François OuimetteEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France. jean-francois.ouimette@curie.fr.ORCID http://orcid.org/0000-0002-4191-6336
Claire RougeulleEpigenetics and Cell Fate, Université Paris Cité, CNRS, Paris, France. claire.rougeulle@curie.fr.ORCID http://orcid.org/0000-0003-3861-4940
Vincent PasqueDepartment of Development and Regeneration, KU Leuven, Leuven, Belgium. vincent.pasque@kuleuven.be.ORCID http://orcid.org/0000-0002-5129-0146

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-10-EQPX-03Agence Nationale de la Recherche (French National Research Agency) ANR-10-INBS-09-08Agence Nationale de la Recherche (French National Research Agency) ANR-14-CE10-0017EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101020423Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11L0722NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11N3122NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1263323NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 1S75720NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0B4420NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0C9320NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0I7822NKU Leuven (Katholieke Universiteit Leuven) C14/21/19KU Leuven (Katholieke Universiteit Leuven) C16/25/020KU Leuven (Katholieke Universiteit Leuven) GSF/26/062KU Leuven (Katholieke Universiteit Leuven) IDN/25/004RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BBS/E/B/000C0521RCUK | Medical Research Council (MRC) MR/T011769/1RCUK | Medical Research Council (MRC) MR/V02969X/1Wellcome Trust (Wellcome) 215116/Z/18/ZWellcome Trust (Wellcome) 221856/Z/20/ZWellcome Trust (Wellcome) 225839/Z/22/Z
6 · The paper itself

Abstract

X-chromosome inactivation (XCI) is essential for extraembryonic tissue growth and embryo development in mice. However, species-specific differences in its timing and regulation have left its role in human development unclear. Here, we show that the in vitro differentiation of naive human pluripotent stem cells to trophoblast stem cells and extraembryonic mesoderm cells is accompanied by XCI. The inactive X chromosome displays an atypical chromatin state, lacking DNA methylation and canonical heterochromatin marks. We demonstrate that extraembryonic differentiation and XCI are temporally linked. Using loss of function approaches, we found that XIST is required for XCI establishment in humans. Furthermore, we show that XCI is needed for the survival of human female extraembryonic cells. Together, these findings link XCI to the formation of human extraembryonic lineages, with important implications for human reproductive biology.

Indexed as

Chromosomes, Human, XRNA, Long NoncodingX Chromosome InactivationAnimalsCell DifferentiationDNA MethylationFemaleHumansMesodermPluripotent Stem CellsTrophoblastsRNA, Long NoncodingXIST non-coding RNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.